Evidence map›Paper›PMID 21541066›Full record

ArticleInternational journal of molecular sciences2011

Anchoring intrinsically disordered proteins to multiple targets: lessons from N-terminus of the p53 protein.

Yongqi Huang, Zhirong Liu

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Binding cavities and druggability of intrinsically disordered proteins.Protein science : a publication of the Protein Society · 2015
    Article
  5. Advantages of proteins being disordered.Protein science : a publication of the Protein Society · 2014
    Review
  6. Molecular dynamics of the full-length p53 monomer.Cell cycle (Georgetown, Tex.) · 2013
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yongqi HuangState Key Laboratory for Structural Chemistry of Unstable and Stable Species, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
Zhirong Liu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anchor residues, which are deeply buried upon binding, play an important role in protein-protein interactions by providing recognition specificity and facilitating the binding kinetics. Up to now, studies on anchor residues have been focused mainly on ordered proteins. In this study, we investigated anchor residues in intrinsically disordered proteins (IDPs) which are flexible in the free state. We identified the anchor residues of the N-terminus of the p53 protein (Glu17-Asn29, abbreviated as p53N) which are involved in binding with two different targets (MDM2 and Taz2), and analyzed their side chain conformations in the unbound states. The anchor residues in the unbound p53N were found to frequently sample conformations similar to those observed in the bound complexes (i.e., Phe19, Trp23, and Leu26 in the p53N-MDM2 complex, and Leu22 in the p53N-Taz2 complex). We argue that the bound-like conformations of the anchor residues in the unbound state are important for controlling the specific interactions between IDPs and their targets. Further, we propose a mechanism to account for the binding promiscuity of IDPs in terms of anchor residues and molecular recognition features (MoRFs).

Indexed as

Molecular Dynamics SimulationAmino Acid SequenceAnimalsBinding SitesHumansIntrinsically Disordered ProteinsMolecular Docking SimulationMolecular Sequence DataProtein BindingProto-Oncogene Proteins c-mdm2Transcription FactorsTumor Suppressor Protein p53Intrinsically Disordered ProteinsProto-Oncogene Proteins c-mdm2Transcription FactorsTumor Suppressor Protein p53anchor residuebinding promiscuityintrinsically disordered proteinsMDM2molecular recognition featuresp53Taz2

Identifiers

PMID21541066
PMCPMC3083713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.